We are requesting NINDS funding for continued support of the NeuroProteomics Core Facility within the Center for Advanced Proteomics Research (CAPR) at the University of Medicine and Dentistry of New Jersey (UMDNJ). During the past funding period, this Core has successfully advanced both neuroscience research and educational missions. It has provided NINDS researchers access to advanced proteomics technologies, and has served as a hub for collaborations and new technology developments. In this renewal application, we are proposing to provide NINDS-funded Pi's with access to the latest state-of-the- art technologies with upgraded Core equipments. These expanded capabilities include an Applied Biosystems 4800 tandem mass spectrometer and other latest proteomics equipments for high throughput protein biomarker discovery and validation. Critical functions that will be fulfilled by these technology upgrades include: 1) more sensitive identification and 2) quantification of protein phosphorylation sites and other post-translational modifications, these systems will significantly enhance the productivity of the eleven qualifying and other neuroscience research projects (including over 30 NINDS investigators). Successful application of proteomics requires both advanced instrumentation and experienced operators. A NINDS core grant will provide dedicated personnel proficient in sample preparation, 2D gel electrophoresis, mass spectrometry and bioinformatics, as well as instrument time and supplies associated with NINDS qualifying projects, a resource that will not overlap with existing facilities. To ensure the continuous success of the Core, UMDNJ has provided excellent institutional commitments towards this Core including new laboratory space, instrumentation upgrade and salary support for the supporting personnel. Two committees, composed of both NINDS and other CAPR investigators, will oversee the Core's fiscal and scientific management. A User Club will provide an important forum for education, training, data sharing and collaborations. As demonstrated by the Core's past record of success and its sound scientific and financial management structure, this improved Core will be well utilized to enhance research capabilities for NINDS-sponsored studies of human diseases including multiple sclerosis, Parkinson's and other neurodegenerative diseases. With the benefit of a NINDS grant, neuroscience investigators will use proteomics technology to maximum benefits, to complement their existing research approaches and promote new research directions and collaborations.

Public Health Relevance

We are requesting NINDS funding for the continued support of the NeuroProteomics Core Facility at the University of Medicine and Dentistry of New Jersey. This facility will improve our researchers'ability to study protein abnormalities in neurodegeneration, aging and other diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Center Core Grants (P30)
Project #
5P30NS046593-09
Application #
8396385
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Talley, Edmund M
Project Start
2003-07-01
Project End
2013-06-30
Budget Start
2012-12-01
Budget End
2013-06-30
Support Year
9
Fiscal Year
2013
Total Cost
$258,620
Indirect Cost
$92,838
Name
University of Medicine & Dentistry of NJ
Department
Biochemistry
Type
Schools of Medicine
DUNS #
623946217
City
Newark
State
NJ
Country
United States
Zip Code
07107
Tasker, Carley; Subbian, Selvakumar; Gao, Pan et al. (2016) IFN-ε protects primary macrophages against HIV infection. JCI Insight 1:e88255
Sugino, Ilene K; Sun, Qian; Springer, Carola et al. (2016) Two Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's Membrane. Transl Vis Sci Technol 5:8
Beuve, Annie; Wu, Changgong; Cui, Chuanlong et al. (2016) Identification of novel S-nitrosation sites in soluble guanylyl cyclase, the nitric oxide receptor. J Proteomics 138:40-7
Hsieh, Lu-Sheng; Su, Wen-Min; Han, Gil-Soo et al. (2016) Phosphorylation of Yeast Pah1 Phosphatidate Phosphatase by Casein Kinase II Regulates Its Function in Lipid Metabolism. J Biol Chem 291:9974-90
Kabaria, Savan; Choi, Doo Chul; Chaudhuri, Amrita Datta et al. (2015) MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression. Free Radic Biol Med 89:548-56
Heckler, Erin J; Kholodovych, Vladyslav; Jain, Mohit et al. (2015) Mapping Soluble Guanylyl Cyclase and Protein Disulfide Isomerase Regions of Interaction. PLoS One 10:e0143523
Pimenta, Erica Maria; Barnes, Betsy J (2015) A conserved region within interferon regulatory factor 5 controls breast cancer cell migration through a cytoplasmic and transcription-independent mechanism. Mol Cancer 14:32
Sriram, G; Jankowski, W; Kasikara, C et al. (2015) Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk. Oncogene 34:4260-9
Stockton Jr, Steven D; Gomes, Ivone; Liu, Tong et al. (2015) Morphine Regulated Synaptic Networks Revealed by Integrated Proteomics and Network Analysis. Mol Cell Proteomics 14:2564-76
Krishnan, Harini; Retzbach, Edward P; Ramirez, Maria I et al. (2015) PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motility. Exp Cell Res 335:115-22

Showing the most recent 10 out of 64 publications